Simon Lowth, chief financial officer at AstraZeneca, is going to leave the pharma company at the end of October to join the oil and gas group BG. Lowth, who joined AstraZeneca in 2007, is ...

Simon Lowth, Interim Chief Executive Officer at AstraZeneca, comments on the results. AZ’s core EPS target range for the full year is expected to maintain at US$5.85 to $6.15. This is largely ...